AIDS.gov Blog UpdateU.S. Dept. of Health & Human Services sent this bulletin at 12/09/2013 02:10 PM EST AIDS.gov Blog for U.S. Dept. of Health & Human Services.
This information has recently been updated, and is now available.
12/09/2013 01:55 PM EST
Drug is third with breakthrough therapy designation to receive FDA approval The U.S. Food and Drug Administration today approved Sovaldi (sofosbuvir) to treat chronic hepatitis C virus (HCV) infection. Sovaldi is the first drug that has demonstrated safety and efficacy to treat certain types of HCV infection without the need for co-administration of interferon. “Today’s...